# BIOPIX DNA TECHNOLOGY P.C.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biopix-dna-technology-p-c

- Industry: Medical Devices & Equipment
- Headquarters: Greece
- Website: www.biopix-t.com
- Total disclosed funding: $5.9M
- Latest round: Series A (Sep 20, 2024)
- Investors on record: 2

## About

BIOPIX DNA TECHNOLOGY P.C. develops innovative molecular diagnostic solutions primarily focused on rapid testing technologies for various infectious diseases and health management applications.Founded in 2019 in Greece, BIOPIX DNA TECHNOLOGY P.C. specializes in molecular diagnostics. The company has raised EUR 1.4 million in a Seed round in April 2021 from Eleven Ventures and Metavallon VC, targeting the health sector with advanced testing solutions. George Papadakis serves as CEO, contributing to the company’s vision and growth.BIOPIX-T specializes in innovative molecular diagnostic solutions, focusing on rapid testing technologies for infectious diseases, pharmacogenomics, and more. Their Pebble device utilizes real-time colorimetric LAMP (qcLAMP) technology to provide results quickly. Their flagship product, the AmpliPan Malaria Test Kit, aims to support global malaria detection efforts. They cater to healthcare providers and patients in diverse markets, including Europe and North America.In 2023, BIOPIX-T reported revenue of EUR 29,264.70, although the company experienced an EBITDA loss of EUR 212,297.30. Revenue is generated through direct sales of diagnostic devices and test kits aimed at healthcare institutions and laboratories, supporting disease management and prevention.Following their EUR 1.4 million Seed round in April 2021, BIOPIX DNA TECHNOLOGY P.C. plans to utilize this funding for operational set-up, product expansion, initial production, and distribution. The company aims to introduce new products, enhance market presence, and expand into additional regions, ensuring accessibility in healthcare markets globally.

## Funding rounds

- Series A, Sep 20, 2024, $2.5M — Eleven Ventures, Metavallon VC
- Seed, Apr 7, 2021, $1.6M — Eleven Ventures, Metavallon VC
- Seed, Sep 9, 2020, $1.7M — Metavallon VC

## Investors

- Metavallon VC (https://capitalatlas.ai/funds/metavallon-vc) — Seed, Series A
- Eleven Ventures — Seed, Series A